$2.23T
Total marketcap
$61.55B
Total volume
BTC 56.22%     ETH 9.01%
Dominance
us

Sernova Biotherapeutics SEOVF Stock

$0.11   -8.333331%
Add to favorites
Market Cap
$41.54M
LOW - HIGH [24H]
$0.11 - $0.11
VOLUME [24H]
$30.50K
P/E Ratio
0
Earnings per share
-$0.03
ISIN
CA81752F1062

Sernova Biotherapeutics Price Chart

Sorry, that's all we've gotfor now...

Sernova Biotherapeutics SEOVF Financial and Trading Overview

Sernova Biotherapeutics stock price 0.11 USD
Previous Close 0.11 USD
Open 0.12 USD
Bid 0.11 USD x 1000000
Ask 0.12 USD x 1500000
Day's Range 0.12 - 0.12 USD
52 Week Range 0.09 - 0.16 USD
Volume 5K USD
Avg. Volume 24.79K USD
Market Cap 43.38M USD
Beta (5Y Monthly) 0.66
PE Ratio (TTM) N/A
EPS (TTM) -0.03 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

SEOVF Valuation Measures

Enterprise Value 57.99M USD
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) N/A
Price/Book (mrq) N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -5.72

Trading Information

Sernova Biotherapeutics Stock Price History

Beta (5Y Monthly) 0.66
52-Week Change 0%
S&P500 52-Week Change 22.66%
52 Week High 0.16 USD
52 Week Low 0.09 USD
50-Day Moving Average 0.12 USD
200-Day Moving Average 0.11 USD

SEOVF Share Statistics

Avg. Volume (3 month) 24.79K USD
Avg. Daily Volume (10-Days) 35.85K USD
Shares Outstanding 361.49M
Float 326.77M
Short Ratio N/A
% Held by Insiders 13.17%
% Held by Institutions 0.040%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends October 31, 2025
Most Recent Quarter (mrq) April 30, 2026
Next Fiscal Year End October 31, 2026

Profitability

Profit Margin 0%
Operating Margin (ttm) 0%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -238.26%
Return on Equity (ttm) N/A

Income Statement

Revenue (ttm) N/A
Revenue Per Share (ttm) N/A
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) N/A
EBITDA -10137448 USD
Net Income Avi to Common (ttm) -11905441 USD
Diluted EPS (ttm) -0.03
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 1.05M USD
Total Cash Per Share (mrq) 0.003 USD
Total Debt (mrq) 2.45M USD
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) 0.139
Book Value Per Share (mrq) -0.04073391

Cash Flow Statement

Operating Cash Flow (ttm) -5498094 USD
Levered Free Cash Flow (ttm) -15609726 USD

Profile of Sernova Biotherapeutics

Country United States
State ON
City Mississauga
Address RPO Central Parkway
ZIP L5A 4H2
Phone 917-751-5713
Website https://www.sernova.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 8

Sernova Biotherapeutics Inc operates as a clinical-stage biotechnology company in Canada. The company develops regenerative medicine therapeutics comprising proprietary Cell Pouch, a bio-hybrid organ system to replicate natural body functions. Its Cell Pouch creates vascularized organs for the longevity and functionality of therapeutic cells and ensures containment for retrievability. Sernova Biotherapeutics Inc was formerly known as Sernova Corp. and changed its name to Sernova Biotherapeutics Inc in February 2025. Sernova Biotherapeutics Inc is based in Mississauga, Canada.

Q&A For Sernova Biotherapeutics Stock

What is a current SEOVF stock price?

Sernova Biotherapeutics SEOVF stock price today per share is 0.11 USD.

How to purchase Sernova Biotherapeutics stock?

You can buy SEOVF shares on the OTC Markets OTCQB exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Sernova Biotherapeutics?

The stock symbol or ticker of Sernova Biotherapeutics is SEOVF.

Which industry does the Sernova Biotherapeutics company belong to?

The Sernova Biotherapeutics industry is Biotechnology.

How many shares does Sernova Biotherapeutics have in circulation?

The max supply of Sernova Biotherapeutics shares is 377.64M.

What is Sernova Biotherapeutics Price to Earnings Ratio (PE Ratio)?

Sernova Biotherapeutics PE Ratio is now.

What was Sernova Biotherapeutics earnings per share over the trailing 12 months (TTM)?

Sernova Biotherapeutics EPS is -0.03 USD over the trailing 12 months.

Which sector does the Sernova Biotherapeutics company belong to?

The Sernova Biotherapeutics sector is Healthcare.

Select currency